D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 125 Citations 65,015 782 World Ranking 1267 National Ranking 757

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

Patrick Y. Wen focuses on Internal medicine, Oncology, Glioma, Surgery and Clinical trial. His research combines Brain tumor and Internal medicine. His studies in Oncology integrate themes in fields like Incidence, Cediranib, Temozolomide, Tumor progression and Pharmacology.

His Glioma research is multidisciplinary, relying on both Neoplasm Grading, Chemotherapy regimen, Progression-free survival and Pathology. Patrick Y. Wen has included themes like Gastroenterology and Hazard ratio in his Surgery study. The various areas that Patrick Y. Wen examines in his Clinical trial study include Randomized controlled trial, Intensive care medicine, Pseudoprogression, Glioblastoma and Response assessment.

His most cited work include:

  • Malignant Gliomas in Adults (3037 citations)
  • Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group (2349 citations)
  • Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma (1837 citations)

What are the main themes of his work throughout his whole career to date?

Patrick Y. Wen mostly deals with Internal medicine, Oncology, Glioma, Surgery and Cancer research. In his work, Newly diagnosed is strongly intertwined with Glioblastoma, which is a subfield of Internal medicine. His Oncology research is multidisciplinary, incorporating elements of Cancer, Clinical trial, Pathology and Chemotherapy.

The concepts of his Clinical trial study are interwoven with issues in Brain tumor and Intensive care medicine. His Glioma research includes elements of Pharmacokinetics, Pharmacology, Angiogenesis and Mutant, IDH1. Surgery is closely attributed to Gastroenterology in his work.

He most often published in these fields:

  • Internal medicine (53.87%)
  • Oncology (43.96%)
  • Glioma (25.70%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (53.87%)
  • Oncology (43.96%)
  • Cancer research (16.51%)

In recent papers he was focusing on the following fields of study:

Patrick Y. Wen mainly focuses on Internal medicine, Oncology, Cancer research, Glioma and Glioblastoma. His study in Internal medicine focuses on Bevacizumab, Recurrent glioblastoma, Progression-free survival, Phases of clinical research and Clinical trial. His Clinical trial research integrates issues from Neurologic Oncology, Response assessment and Intensive care medicine.

His study on Oncology also encompasses disciplines like

  • Radiation therapy which intersects with area such as Chemotherapy and Meningioma,
  • Temozolomide which is related to area like Cancer. His Cancer research study combines topics in areas such as T cell, Immune system, Immunotherapy and PI3K/AKT/mTOR pathway. His studies deal with areas such as Pharmacokinetics, Mutant and Pathology as well as Glioma.

Between 2017 and 2021, his most popular works were:

  • Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial (356 citations)
  • Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. (309 citations)
  • Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer (230 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

His primary areas of investigation include Internal medicine, Oncology, Clinical trial, Glioma and Cancer research. As part of his studies on Internal medicine, he frequently links adjacent subjects like Gastroenterology. His study in Oncology is interdisciplinary in nature, drawing from both Survival rate, Radiation therapy, Glioblastoma, Temozolomide and Biomarker.

His research on Clinical trial also deals with topics like

  • Intensive care medicine which is related to area like Cancer, Cooperative group and Patient advocacy,
  • Magnetic resonance imaging and Dosing most often made with reference to Brain tumor. His research in Glioma intersects with topics in Isocitrate dehydrogenase, Disease and IDH1. His work deals with themes such as Immune checkpoint, Immunotherapy, T cell, Receptor and PI3K/AKT/mTOR pathway, which intersect with Cancer research.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Malignant Gliomas in Adults

Patrick Y Wen;Santosh Kesari.
The New England Journal of Medicine (2008)

4113 Citations

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

Patrick Y. Wen;David R. Macdonald;David A. Reardon;Timothy F. Cloughesy.
Journal of Clinical Oncology (2010)

2941 Citations

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

Henry S. Friedman;Michael D. Prados;Patrick Y. Wen;Tom Mikkelsen.
Journal of Clinical Oncology (2009)

2450 Citations

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Tracy T. Batchelor;A. Gregory Sorensen;A. Gregory Sorensen;Emmanuelle di Tomaso;Wei Ting Zhang;Wei Ting Zhang.
Cancer Cell (2007)

1943 Citations

Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma

Erwin Van Meir;Constantinos G Hadjipanayis;Andrew D. Norden;Hui-Kuo Shu.
CA: A Cancer Journal for Clinicians (2010)

1409 Citations

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

A. D. Norden;G. S. Young;K. Setayesh;A. Muzikansky.
Neurology (2008)

915 Citations

Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Report of the Quality Standards Subcommittee of the American Academy of Neurology

M. J. Glantz;B. F. Cole;B. F. Cole;P. A. Forsyth;L. D. Recht;L. D. Recht.
Neurology (2000)

875 Citations

Epidemiology of Brain Metastases

Lakshmi Nayak;Eudocia Quant Lee;Patrick Y. Wen.
Current Oncology Reports (2012)

773 Citations

Stereotactic Radiosurgery for the Definitive, Noninvasive Treatment of Brain Metastases

Eben Alexander;Thomas M. Moriarty;Roger B. Davis;Patrick Y. Wen.
Journal of the National Cancer Institute (1995)

739 Citations

Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib

Paul G. Richardson;Hannah Briemberg;Sundar Jagannath;Patrick Y. Wen.
Journal of Clinical Oncology (2006)

708 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Patrick Y. Wen

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 220

Michael Weller

Michael Weller

University of Zurich

Publications: 216

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 139

David A. Reardon

David A. Reardon

Harvard University

Publications: 134

Mark R. Gilbert

Mark R. Gilbert

The University of Texas MD Anderson Cancer Center

Publications: 126

Rakesh K. Jain

Rakesh K. Jain

Harvard University

Publications: 117

Tracy T. Batchelor

Tracy T. Batchelor

Brigham and Women's Hospital

Publications: 98

Roger Stupp

Roger Stupp

Northwestern University

Publications: 94

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 93

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 92

Jeremy N. Rich

Jeremy N. Rich

University of Pittsburgh

Publications: 92

Matthias Preusser

Matthias Preusser

Medical University of Vienna

Publications: 91

Susan M. Chang

Susan M. Chang

University of California, San Francisco

Publications: 90

Minesh P. Mehta

Minesh P. Mehta

University of Maryland, Baltimore

Publications: 87

Marc C. Chamberlain

Marc C. Chamberlain

University of Washington

Publications: 83

Tao Jiang

Tao Jiang

Capital Medical University

Publications: 83

Something went wrong. Please try again later.